New Cloud-Based Investigator Portal from Veeva Systems Speeds Clinical Study Start-Up

Single source for sponsor, CRO and investigator collaboration

During the Drug Information Association's (DIA) annual meeting today, Veeva Systems previewed its new Veeva Vault Investigator Portal. As a companion product to Vault eTMF, Vault Investigator Portal enables fast collection, sharing and tracking of all investigator content from a single platform. Veeva has specifically designed its new Investigator Portal to speed study start-up by simplifying the overall trial document management process and providing bi-directional, direct access to the eTMF.

     (Logo: http://photos.prnewswire.com/prnh/20120425/527164 )

     (Photo: http://photos.prnewswire.com/prnh/20130624/622707 )

Clinical trials are one of the most complex areas of a life sciences company's operations, requiring global reach, coordination and tracking across multiple stakeholders. Investigators and site personnel spend hundreds of hours performing redundant tasks across multiple sponsors and systems. Most trial technologies hinder investigator efficiency and breed frustration. Veeva's cloud-based Vault Investigator Portal orchestrates collaboration with site personnel for more efficient operations.

"Without a doubt, the back and forth between investigators and the CRO or sponsor is causing huge delays in study start-up. Most of these documents are still exchanged as paper, which is slow and adds expense. Sponsors and CROs must find ways to improve the efficiency while protecting the increasingly important site relationship," said Michael Burton, director of clinical product strategy at Veeva.

Veeva's Vault Investigator Portal helps streamline trials and increase efficiency with features that lessen the workload for sponsors and investigators, including:  

  • Single source for sponsors, CROs and investigator sites to submit and access documents
  • Direct placement of site documents into the eTMF
  • Two-way channel for exchanging documents, including safety alerts and site training videos
  • Prioritised to-do lists and associated documents packaged and pushed to investigator sites

"With Vault Investigator Portal, sponsors and CROs will benefit from better document tracking and placement into the eTMF," concluded Burton. "The ease-of-use and efficiency for investigators will make working with the sponsor and CRO more attractive, which should keep investigators coming back for trial after trial."

Also announced at DIA 2013 today, Veeva adds critical publishing capabilities to Vault Submissions - the industry's first cloud-based application for managing submissions content.

About Veeva Vault Development Suite

Vault Investigator Portal is part of the Veeva Development Suite, the only cloud-based suite of integrated content management applications for the life sciences industry. Spanning every major part of a life sciences company - from R&D to clinical trials, to quality and manufacturing - the Veeva Development Suite gives pharmaceutical, biotechnology and medical device companies the ability to deploy a single content management system globally. All Development Suite applications offer real-time reporting and dashboards, an intuitive web interface, and a true multitenant cloud architecture that continuously delivers rapid innovation.

About Veeva Systems
Veeva Systems is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence and customer success, Veeva has over 150 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. Founded in 2007, Veeva is a privately held company headquartered in the San Francisco Bay Area, with offices in PhiladelphiaBarcelonaBudapestLondonParisBeijingShanghai and Tokyo. For more information, visithttp://www.veeva.com.

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.